Action: mequinol works by inhibiting the production of melanin. In hyperpigmentation disorders, such as melasma, there is an overproduction of melanin, leading to dark patches or spots.
mequinol interferes with the enzymatic steps involved in melanin synthesis, particularly the conversion of dopaquinone to melanin. By inhibiting this process, mequinol helps to lighten the darkened areas of the skin and promote a more even skin tone.
Spectrum: mequinol is primarily effective in treating hyperpigmentation disorders, including:
Melasma: It is a skin condition characterized by dark patches on the skin, often on the face. It is often triggered by hormonal changes, such as pregnancy or birth control use, and is exacerbated by sun exposure.
Post-Inflammatory Hyperpigmentation (PIH): It is an inflammation or injury of skin such as acne, burns, or cuts. Once the skin heals, it can leave behind dark spots that persist for some time.
Apply topical solution containing mequinol (20 mg/1mL) and Tretinoin (0.1 mg/1mL) to the affected region of skin twice a day (morning and evening), a minimum of 8 hours apart
Safety and efficacy were not established
Refer to the adult dosing regimen
Frequency not defined
Itching
redness of skin
skin irritation
dry skin
Crusting of skin
skin rash
Large blisters on skin
Burning feeling, tingling, or stinging of skin
peeling of skin
Black Box Warning:
There were no specific black box warnings associated with the use of mequinol.
Contraindication/Caution:
Contraindication:
Hypersensitivity or Allergic Reactions: Individuals who have a known hypersensitivity or allergy to mequinol or any other ingredient in the formulation should avoid using products containing mequinol.
Active Skin Infections: mequinol should not be used on skin that has active infections, as it may worsen the condition or interfere with the healing process.
Skin Sensitivity or Eczema: Individuals with sensitive skin or skin conditions like eczema should exercise caution when using mequinol. It might cause irritation or exacerbate existing skin problems.
Sunburned or Windburned Skin: mequinol should not be applied to skin, which is sunburned, windburned, chapped, or otherwise irritated. Applying mequinol to damaged skin can lead to increased irritation and discomfort.
Children: The use of mequinol in children should be used under caution. Children’s skin tends to be more sensitive, and certain conditions might affect the suitability of using Mequinol.
Caution:
Discoloration: While mequinol is used to treat hyperpigmentation, incorrect use or overuse could potentially lead to skin discoloration or uneven skin tone.
Sun Sensitivity: mequinol-treated skin can become more sensitive to the sun. It is crucial to use broad-spectrum sunscreen with a high sun protection factor (SPF) and practice sun-protective behaviors, such as wearing protective clothing and seeking shade, to prevent further skin damage.
Combination Therapy: mequinol is often used in combination with other depigmenting agents, such as tretinoin (a form of vitamin A), to enhance its effects. It is important to follow the recommended combination therapy regimen prescribed by a healthcare professional.
Duration of Use: The duration of mequinol treatment can vary based on the specific condition being treated. Overusing mequinol or using it for longer than recommended might lead to adverse effects or decreased effectiveness.
Pregnancy and Breastfeeding: If you are pregnant or breastfeeding, it is important to discuss the use of mequinol with your healthcare provider. The safety of mequinol in these situations is not fully established, and professional guidance is recommended.
Comorbidities:
Skin Sensitivities: Individuals with sensitive skin or a history of skin reactions might be more prone to irritation when using mequinol.
Allergies: If you have known allergies to ingredients commonly found in skincare products, it is important to review the ingredient list of mequinol-containing products to ensure they are safe for use.
Underlying Skin Conditions: If you have existing skin conditions, such as eczema, psoriasis, or dermatitis, it is advisable to consult a dermatologist before using mequinol. Some skin conditions can be exacerbated by certain treatments.
Pregnancy and Breastfeeding: It is recommended to consult with a healthcare professional before using mequinol during pregnancy and breastfeeding, as the safety of mequinol in these situations is not fully established.
Medical History: If you have a history of medical conditions, especially autoimmune disorders or conditions affecting the skin, consult with a healthcare provider before using mequinol.
Pregnancy consideration: pregnancy category: not assigned
Lactation: excreted into breast milk: unknown
Pregnancy category:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category.
Pharmacology:
mequinol is a depigmenting agent used in dermatology to treat hyperpigmentation disorders. mequinol inhibits the activity of tyrosinase, which is plays an important role in synthesis of melanin.
Melanin is produced by melanocytes, specialized skin cells that determine our skin color. The synthesis of melanin involves several steps, and tyrosinase converts tyrosine into melanin precursors.
By inhibiting tyrosinase activity, mequinol reduces the production of melanin precursors, which leads to decreased melanin production in the skin. This results in lightening of the darkened areas of the skin and a more even skin tone.
Pharmacodynamics:
Inhibition of Melanin Production: Hyperpigmentation occurs when there is an overproduction of melanin in the skin, leading to dark patches or spots. mequinol acts as a competitive inhibitor of tyrosinase which is involved in synthesis of melanin. By inhibiting tyrosinase, mequinol reduces the conversion of tyrosine (an amino acid) into melanin precursors, thereby decreasing melanin production.
Reduction of Melanin Content: Through its inhibitory effect on tyrosinase, mequinol reduces the overall amount of melanin present in the skin’s cells. This leads to a gradual lightening of the hyperpigmented areas which results in a more even skin tone.
Selectivity for Melanocytes: mequinol’s action is selective for melanocytes, the specialized skin cells responsible for producing melanin. This selectivity helps target the areas where excess melanin is being produced while minimizing effects on surrounding normal skin cells.
Combination Therapy: mequinol is often used in combination with other agents, such as tretinoin (a derivative of vitamin A), to enhance its effects. Combination therapy can increase the penetration of mequinol into the skin and optimize its depigmenting action.
Pharmacokinetics:
Absorption
mequinol is applied topically to the skin, typically in the form of creams or lotions. It is designed to be absorbed into the upper layers of the skin (epidermis). mequinol is absorbed primarily through the skin’s outer layer and is not intended for systemic absorption into the bloodstream.
Distribution
After topical application, mequinol remains localized in the skin’s treated area. Its distribution beyond the application site is minimal, as it is designed to target the melanin-producing cells (melanocytes) within the skin.
Metabolism
mequinol is not significantly metabolized within the body. It primarily acts on the skin’s surface and interacts with the enzymes involved in melanin synthesis.
Elimination and excretion
mequinol is not typically excreted through the usual routes of renal or hepatic excretion since its intended action is primarily localized to the skin.
Administration:
Cleanse the Skin: Before applying mequinol, ensure that the skin is clean and dry. Gently cleanse the area using a mild cleanser & pat dry with a clean towel.
Patch Test: If you are using mequinol for the first time, consider performing a patch test on a small area of skin. This helps to identify any potential allergic reactions or irritation before applying the product to a larger area.
Application: Apply a thin layer of the mequinol-containing product to the hyperpigmented areas of the skin. Use clean fingertips or a clean applicator to gently spread the product. Avoid applying mequinol to unaffected areas of the skin.
Avoid Eyes and Lips: Be cautious to avoid contact with the eyes, lips, and other sensitive areas.
Why do we use mequinol/gluconolactone/ lactobionic acid/ arbutin?
Melasma: It is the skin condition characterized by the development of dark patches on the skin, typically on the face. It is triggered by hormonal changes like pregnancy or birth control use, and is exacerbated by sun exposure. mequinol is used to lighten these dark patches and achieve a more even skin tone.
Post-Inflammatory Hyperpigmentation (PIH): It occurs as a result of inflammation or injury to skin like acne, burns, cuts, or other skin trauma. After the initial skin issue heals, it can leave behind dark spots that persist for some time. mequinol can help lighten these dark spots and promote a more uniform skin appearance.
General Hyperpigmentation: mequinol can also be used to treat other forms of hyperpigmentation not specifically classified as melasma or PIH. This includes areas of uneven skin tone caused by various factors.
Combination Therapy: mequinol is often used in combination with other agents, such as tretinoin (a form of vitamin A), to enhance its effects. This combination therapy can improve the efficacy of treatment and lead to better results.
Apply topical solution containing mequinol (20 mg/1mL) and Tretinoin (0.1 mg/1mL) to the affected region of skin twice a day (morning and evening), a minimum of 8 hours apart
No Drug Intearction Found. for mequinol/gluconolactone/ lactobionic acid/ arbutin and .
Actions and spectrum:
Action: mequinol works by inhibiting the production of melanin. In hyperpigmentation disorders, such as melasma, there is an overproduction of melanin, leading to dark patches or spots.
mequinol interferes with the enzymatic steps involved in melanin synthesis, particularly the conversion of dopaquinone to melanin. By inhibiting this process, mequinol helps to lighten the darkened areas of the skin and promote a more even skin tone.
Spectrum: mequinol is primarily effective in treating hyperpigmentation disorders, including:
Melasma: It is a skin condition characterized by dark patches on the skin, often on the face. It is often triggered by hormonal changes, such as pregnancy or birth control use, and is exacerbated by sun exposure.
Post-Inflammatory Hyperpigmentation (PIH): It is an inflammation or injury of skin such as acne, burns, or cuts. Once the skin heals, it can leave behind dark spots that persist for some time.
Frequency not defined
Itching
redness of skin
skin irritation
dry skin
Crusting of skin
skin rash
Large blisters on skin
Burning feeling, tingling, or stinging of skin
peeling of skin
Black Box Warning:
There were no specific black box warnings associated with the use of mequinol.
Contraindication/Caution:
Contraindication:
Hypersensitivity or Allergic Reactions: Individuals who have a known hypersensitivity or allergy to mequinol or any other ingredient in the formulation should avoid using products containing mequinol.
Active Skin Infections: mequinol should not be used on skin that has active infections, as it may worsen the condition or interfere with the healing process.
Skin Sensitivity or Eczema: Individuals with sensitive skin or skin conditions like eczema should exercise caution when using mequinol. It might cause irritation or exacerbate existing skin problems.
Sunburned or Windburned Skin: mequinol should not be applied to skin, which is sunburned, windburned, chapped, or otherwise irritated. Applying mequinol to damaged skin can lead to increased irritation and discomfort.
Children: The use of mequinol in children should be used under caution. Children’s skin tends to be more sensitive, and certain conditions might affect the suitability of using Mequinol.
Caution:
Discoloration: While mequinol is used to treat hyperpigmentation, incorrect use or overuse could potentially lead to skin discoloration or uneven skin tone.
Sun Sensitivity: mequinol-treated skin can become more sensitive to the sun. It is crucial to use broad-spectrum sunscreen with a high sun protection factor (SPF) and practice sun-protective behaviors, such as wearing protective clothing and seeking shade, to prevent further skin damage.
Combination Therapy: mequinol is often used in combination with other depigmenting agents, such as tretinoin (a form of vitamin A), to enhance its effects. It is important to follow the recommended combination therapy regimen prescribed by a healthcare professional.
Duration of Use: The duration of mequinol treatment can vary based on the specific condition being treated. Overusing mequinol or using it for longer than recommended might lead to adverse effects or decreased effectiveness.
Pregnancy and Breastfeeding: If you are pregnant or breastfeeding, it is important to discuss the use of mequinol with your healthcare provider. The safety of mequinol in these situations is not fully established, and professional guidance is recommended.
Comorbidities:
Skin Sensitivities: Individuals with sensitive skin or a history of skin reactions might be more prone to irritation when using mequinol.
Allergies: If you have known allergies to ingredients commonly found in skincare products, it is important to review the ingredient list of mequinol-containing products to ensure they are safe for use.
Underlying Skin Conditions: If you have existing skin conditions, such as eczema, psoriasis, or dermatitis, it is advisable to consult a dermatologist before using mequinol. Some skin conditions can be exacerbated by certain treatments.
Pregnancy and Breastfeeding: It is recommended to consult with a healthcare professional before using mequinol during pregnancy and breastfeeding, as the safety of mequinol in these situations is not fully established.
Medical History: If you have a history of medical conditions, especially autoimmune disorders or conditions affecting the skin, consult with a healthcare provider before using mequinol.
Pregnancy consideration: pregnancy category: not assigned
Lactation: excreted into breast milk: unknown
Pregnancy category:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category.
Pharmacology:
mequinol is a depigmenting agent used in dermatology to treat hyperpigmentation disorders. mequinol inhibits the activity of tyrosinase, which is plays an important role in synthesis of melanin.
Melanin is produced by melanocytes, specialized skin cells that determine our skin color. The synthesis of melanin involves several steps, and tyrosinase converts tyrosine into melanin precursors.
By inhibiting tyrosinase activity, mequinol reduces the production of melanin precursors, which leads to decreased melanin production in the skin. This results in lightening of the darkened areas of the skin and a more even skin tone.
Pharmacodynamics:
Inhibition of Melanin Production: Hyperpigmentation occurs when there is an overproduction of melanin in the skin, leading to dark patches or spots. mequinol acts as a competitive inhibitor of tyrosinase which is involved in synthesis of melanin. By inhibiting tyrosinase, mequinol reduces the conversion of tyrosine (an amino acid) into melanin precursors, thereby decreasing melanin production.
Reduction of Melanin Content: Through its inhibitory effect on tyrosinase, mequinol reduces the overall amount of melanin present in the skin’s cells. This leads to a gradual lightening of the hyperpigmented areas which results in a more even skin tone.
Selectivity for Melanocytes: mequinol’s action is selective for melanocytes, the specialized skin cells responsible for producing melanin. This selectivity helps target the areas where excess melanin is being produced while minimizing effects on surrounding normal skin cells.
Combination Therapy: mequinol is often used in combination with other agents, such as tretinoin (a derivative of vitamin A), to enhance its effects. Combination therapy can increase the penetration of mequinol into the skin and optimize its depigmenting action.
Pharmacokinetics:
Absorption
mequinol is applied topically to the skin, typically in the form of creams or lotions. It is designed to be absorbed into the upper layers of the skin (epidermis). mequinol is absorbed primarily through the skin’s outer layer and is not intended for systemic absorption into the bloodstream.
Distribution
After topical application, mequinol remains localized in the skin’s treated area. Its distribution beyond the application site is minimal, as it is designed to target the melanin-producing cells (melanocytes) within the skin.
Metabolism
mequinol is not significantly metabolized within the body. It primarily acts on the skin’s surface and interacts with the enzymes involved in melanin synthesis.
Elimination and excretion
mequinol is not typically excreted through the usual routes of renal or hepatic excretion since its intended action is primarily localized to the skin.
Administration:
Cleanse the Skin: Before applying mequinol, ensure that the skin is clean and dry. Gently cleanse the area using a mild cleanser & pat dry with a clean towel.
Patch Test: If you are using mequinol for the first time, consider performing a patch test on a small area of skin. This helps to identify any potential allergic reactions or irritation before applying the product to a larger area.
Application: Apply a thin layer of the mequinol-containing product to the hyperpigmented areas of the skin. Use clean fingertips or a clean applicator to gently spread the product. Avoid applying mequinol to unaffected areas of the skin.
Avoid Eyes and Lips: Be cautious to avoid contact with the eyes, lips, and other sensitive areas.
Why do we use mequinol/gluconolactone/ lactobionic acid/ arbutin?
Melasma: It is the skin condition characterized by the development of dark patches on the skin, typically on the face. It is triggered by hormonal changes like pregnancy or birth control use, and is exacerbated by sun exposure. mequinol is used to lighten these dark patches and achieve a more even skin tone.
Post-Inflammatory Hyperpigmentation (PIH): It occurs as a result of inflammation or injury to skin like acne, burns, cuts, or other skin trauma. After the initial skin issue heals, it can leave behind dark spots that persist for some time. mequinol can help lighten these dark spots and promote a more uniform skin appearance.
General Hyperpigmentation: mequinol can also be used to treat other forms of hyperpigmentation not specifically classified as melasma or PIH. This includes areas of uneven skin tone caused by various factors.
Combination Therapy: mequinol is often used in combination with other agents, such as tretinoin (a form of vitamin A), to enhance its effects. This combination therapy can improve the efficacy of treatment and lead to better results.
Action: mequinol works by inhibiting the production of melanin. In hyperpigmentation disorders, such as melasma, there is an overproduction of melanin, leading to dark patches or spots.
mequinol interferes with the enzymatic steps involved in melanin synthesis, particularly the conversion of dopaquinone to melanin. By inhibiting this process, mequinol helps to lighten the darkened areas of the skin and promote a more even skin tone.
Spectrum: mequinol is primarily effective in treating hyperpigmentation disorders, including:
Melasma: It is a skin condition characterized by dark patches on the skin, often on the face. It is often triggered by hormonal changes, such as pregnancy or birth control use, and is exacerbated by sun exposure.
Post-Inflammatory Hyperpigmentation (PIH): It is an inflammation or injury of skin such as acne, burns, or cuts. Once the skin heals, it can leave behind dark spots that persist for some time.
Dosing & Uses
Drug Interaction
Adverse Reaction
Frequency not defined
Itching
redness of skin
skin irritation
dry skin
Crusting of skin
skin rash
Large blisters on skin
Burning feeling, tingling, or stinging of skin
peeling of skin
Black Box Warning
Black Box Warning:
There were no specific black box warnings associated with the use of mequinol.
Contraindication / Caution
Contraindication/Caution:
Contraindication:
Hypersensitivity or Allergic Reactions: Individuals who have a known hypersensitivity or allergy to mequinol or any other ingredient in the formulation should avoid using products containing mequinol.
Active Skin Infections: mequinol should not be used on skin that has active infections, as it may worsen the condition or interfere with the healing process.
Skin Sensitivity or Eczema: Individuals with sensitive skin or skin conditions like eczema should exercise caution when using mequinol. It might cause irritation or exacerbate existing skin problems.
Sunburned or Windburned Skin: mequinol should not be applied to skin, which is sunburned, windburned, chapped, or otherwise irritated. Applying mequinol to damaged skin can lead to increased irritation and discomfort.
Children: The use of mequinol in children should be used under caution. Children’s skin tends to be more sensitive, and certain conditions might affect the suitability of using Mequinol.
Caution:
Discoloration: While mequinol is used to treat hyperpigmentation, incorrect use or overuse could potentially lead to skin discoloration or uneven skin tone.
Sun Sensitivity: mequinol-treated skin can become more sensitive to the sun. It is crucial to use broad-spectrum sunscreen with a high sun protection factor (SPF) and practice sun-protective behaviors, such as wearing protective clothing and seeking shade, to prevent further skin damage.
Combination Therapy: mequinol is often used in combination with other depigmenting agents, such as tretinoin (a form of vitamin A), to enhance its effects. It is important to follow the recommended combination therapy regimen prescribed by a healthcare professional.
Duration of Use: The duration of mequinol treatment can vary based on the specific condition being treated. Overusing mequinol or using it for longer than recommended might lead to adverse effects or decreased effectiveness.
Pregnancy and Breastfeeding: If you are pregnant or breastfeeding, it is important to discuss the use of mequinol with your healthcare provider. The safety of mequinol in these situations is not fully established, and professional guidance is recommended.
Comorbidities:
Skin Sensitivities: Individuals with sensitive skin or a history of skin reactions might be more prone to irritation when using mequinol.
Allergies: If you have known allergies to ingredients commonly found in skincare products, it is important to review the ingredient list of mequinol-containing products to ensure they are safe for use.
Underlying Skin Conditions: If you have existing skin conditions, such as eczema, psoriasis, or dermatitis, it is advisable to consult a dermatologist before using mequinol. Some skin conditions can be exacerbated by certain treatments.
Pregnancy and Breastfeeding: It is recommended to consult with a healthcare professional before using mequinol during pregnancy and breastfeeding, as the safety of mequinol in these situations is not fully established.
Medical History: If you have a history of medical conditions, especially autoimmune disorders or conditions affecting the skin, consult with a healthcare provider before using mequinol.
Pregnancy / Lactation
Pregnancy consideration: pregnancy category: not assigned
Lactation: excreted into breast milk: unknown
Pregnancy category:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category.
Pharmacology
Pharmacology:
mequinol is a depigmenting agent used in dermatology to treat hyperpigmentation disorders. mequinol inhibits the activity of tyrosinase, which is plays an important role in synthesis of melanin.
Melanin is produced by melanocytes, specialized skin cells that determine our skin color. The synthesis of melanin involves several steps, and tyrosinase converts tyrosine into melanin precursors.
By inhibiting tyrosinase activity, mequinol reduces the production of melanin precursors, which leads to decreased melanin production in the skin. This results in lightening of the darkened areas of the skin and a more even skin tone.
Pharmacodynamics:
Inhibition of Melanin Production: Hyperpigmentation occurs when there is an overproduction of melanin in the skin, leading to dark patches or spots. mequinol acts as a competitive inhibitor of tyrosinase which is involved in synthesis of melanin. By inhibiting tyrosinase, mequinol reduces the conversion of tyrosine (an amino acid) into melanin precursors, thereby decreasing melanin production.
Reduction of Melanin Content: Through its inhibitory effect on tyrosinase, mequinol reduces the overall amount of melanin present in the skin’s cells. This leads to a gradual lightening of the hyperpigmented areas which results in a more even skin tone.
Selectivity for Melanocytes: mequinol’s action is selective for melanocytes, the specialized skin cells responsible for producing melanin. This selectivity helps target the areas where excess melanin is being produced while minimizing effects on surrounding normal skin cells.
Combination Therapy: mequinol is often used in combination with other agents, such as tretinoin (a derivative of vitamin A), to enhance its effects. Combination therapy can increase the penetration of mequinol into the skin and optimize its depigmenting action.
Pharmacokinetics:
Absorption
mequinol is applied topically to the skin, typically in the form of creams or lotions. It is designed to be absorbed into the upper layers of the skin (epidermis). mequinol is absorbed primarily through the skin’s outer layer and is not intended for systemic absorption into the bloodstream.
Distribution
After topical application, mequinol remains localized in the skin’s treated area. Its distribution beyond the application site is minimal, as it is designed to target the melanin-producing cells (melanocytes) within the skin.
Metabolism
mequinol is not significantly metabolized within the body. It primarily acts on the skin’s surface and interacts with the enzymes involved in melanin synthesis.
Elimination and excretion
mequinol is not typically excreted through the usual routes of renal or hepatic excretion since its intended action is primarily localized to the skin.
Adminstartion
Administration:
Cleanse the Skin: Before applying mequinol, ensure that the skin is clean and dry. Gently cleanse the area using a mild cleanser & pat dry with a clean towel.
Patch Test: If you are using mequinol for the first time, consider performing a patch test on a small area of skin. This helps to identify any potential allergic reactions or irritation before applying the product to a larger area.
Application: Apply a thin layer of the mequinol-containing product to the hyperpigmented areas of the skin. Use clean fingertips or a clean applicator to gently spread the product. Avoid applying mequinol to unaffected areas of the skin.
Avoid Eyes and Lips: Be cautious to avoid contact with the eyes, lips, and other sensitive areas.
Why do we use mequinol/gluconolactone/ lactobionic acid/ arbutin?
Melasma: It is the skin condition characterized by the development of dark patches on the skin, typically on the face. It is triggered by hormonal changes like pregnancy or birth control use, and is exacerbated by sun exposure. mequinol is used to lighten these dark patches and achieve a more even skin tone.
Post-Inflammatory Hyperpigmentation (PIH): It occurs as a result of inflammation or injury to skin like acne, burns, cuts, or other skin trauma. After the initial skin issue heals, it can leave behind dark spots that persist for some time. mequinol can help lighten these dark spots and promote a more uniform skin appearance.
General Hyperpigmentation: mequinol can also be used to treat other forms of hyperpigmentation not specifically classified as melasma or PIH. This includes areas of uneven skin tone caused by various factors.
Combination Therapy: mequinol is often used in combination with other agents, such as tretinoin (a form of vitamin A), to enhance its effects. This combination therapy can improve the efficacy of treatment and lead to better results.
Loading...
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
